Recursion Pharmaceuticals, Inc. financial data

Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
41 S Rio Grande Street, Salt Lake City, UT
State of incorporation
DE
Fiscal year end
December 31
Former names
Recursion Pharmaceuticals, LLC (to 12/4/2015)
Latest financial report
10-K - Q4 2024 - Feb 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 450 % -0.05%
Debt-to-equity 37.9 % -12.4%
Return On Equity -72.9 % +0.01%
Return On Assets -52.9 % -3.87%
Operating Margin -814 % -3.66%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 397M shares +69.4%
Entity Public Float 1.51B USD +62.1%
Common Stock, Value, Issued 4K USD +100%
Weighted Average Number of Shares Outstanding, Basic 274M shares +31.9%
Weighted Average Number of Shares Outstanding, Diluted 274M shares +31.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 58.8M USD +32%
Research and Development Expense 314M USD +30.3%
General and Administrative Expense 178M USD +60.8%
Costs and Expenses 538M USD +36.3%
Operating Income (Loss) -479M USD -36.8%
Nonoperating Income (Expense) 14.2M USD -20.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -465M USD -39.9%
Income Tax Expense (Benefit) -1.13M USD +72.3%
Net Income (Loss) Attributable to Parent -464M USD -41.3%
Earnings Per Share, Basic -1.69 USD/shares -6.96%
Earnings Per Share, Diluted -1.69 USD/shares -6.96%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 594M USD +51.8%
Other Assets, Current 67.7M USD +68.2%
Assets, Current 714M USD +63%
Deferred Income Tax Assets, Net 1.93M USD
Property, Plant and Equipment, Net 141M USD +63.1%
Operating Lease, Right-of-Use Asset 65.9M USD +95.7%
Intangible Assets, Net (Excluding Goodwill) 336M USD +822%
Goodwill 149M USD +186%
Other Assets, Noncurrent 8.83M USD +3281%
Assets 1.45B USD +122%
Accounts Payable, Current 21.6M USD +447%
Employee-related Liabilities, Current 50.9M USD +122%
Accrued Liabilities, Current 81.9M USD +75.6%
Contract with Customer, Liability, Current 61.8M USD +69.6%
Liabilities, Current 187M USD +101%
Long-term Debt and Lease Obligation 19M USD +1628%
Contract with Customer, Liability, Noncurrent 119M USD +132%
Deferred Income Tax Liabilities, Net 16.6M USD +1138%
Operating Lease, Liability, Noncurrent 67.3M USD +54.9%
Other Liabilities, Noncurrent 4.73M USD
Liabilities 414M USD +117%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.43B USD -47.9%
Stockholders' Equity Attributable to Parent 1.03B USD +123%
Liabilities and Equity 1.45B USD +122%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -102M USD -39.5%
Net Cash Provided by (Used in) Financing Activities 13.9M USD +623%
Net Cash Provided by (Used in) Investing Activities -6.65M USD -24.6%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 397M shares +69.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -95.3M USD -24.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 603M USD +50.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13K USD -7.14%
Deferred Tax Assets, Valuation Allowance 466M USD +53%
Deferred Tax Assets, Gross 541M USD +69.1%
Operating Lease, Liability 81M USD +63.6%
Depreciation 18.3M USD +15.1%
Payments to Acquire Property, Plant, and Equipment 6.65M USD +28.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -471M USD -43.7%
Lessee, Operating Lease, Liability, to be Paid 101M USD +52.9%
Property, Plant and Equipment, Gross 204M USD +55.1%
Operating Lease, Liability, Current 13.8M USD +126%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.5M USD +96.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.4M USD +92.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.1M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8M USD +97.7%
Deferred Tax Assets, Operating Loss Carryforwards 274M USD +133%
Unrecognized Tax Benefits 6.75M USD +24.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.8M USD +55.9%
Additional Paid in Capital 2.47B USD +72.9%
Amortization of Intangible Assets 18.8M USD +121%
Depreciation, Depletion and Amortization 7.38M USD +97.9%
Deferred Tax Assets, Net of Valuation Allowance 75.2M USD +383%
Share-based Payment Arrangement, Expense 79.5M USD +53.8%
Interest Expense 98K USD +63.3%